Glucotrack (Nasdaq:GCTK) announced that it completed a strategic business combination with Lōkahi Therapeutics.

Abbott (NYSE:ABT) announced today that the FDA approved the longer length (76 mm) Esprit BTK drug-eluting scaffold system.

Insulet (Nasdaq:PODD) announced today that it has partnered with Calm, a leading consumer mental health company.

Sanofi announced today that the FDA approved the delivery of its Sarclisa anticancer therapy through the Enable Injections on ...

The Omnipod 5 with an iPhone [Image courtesy of Insulet] Insulet (Nasdaq:PODD) announced today that it launched its Omnipod 5 ...

NanoPortal technology held in the hand [Image courtesy of Vivani] Vivani Medical (Nasdaq:VANI) today announced a new agreement with Novo Nordisk to evaluate the NPM-139 long-term semaglutide implant.

Trinity Biotech (Nasdaq:TRIB) today announced new clinical findings supporting its next-generation continuous glucose monitor ...

Left: the Abbott FreeStyle Libre 3 CGM. Right: Medtronic’s MiniMed 780G. [Image courtesy of the companies] Abbott (NYSE:ABT) and Medtronic (NYSE:MDT) today announced a global partnership pairing ...

The Omnipod 5 worn in a swimming pool. [Image courtesy of Insulet] Insulet (Nasdaq:PODD) today revealed plans for its innovation pipeline, which includes the next-generation Omnipod 6 system. At the ...

[Image taken by Sean Whooley at the American Diabetes Association’s 85th Scientific Sessions in Chicago.] The biggest names in diabetes tech gathered in Chicago this past weekend for the American ...

The biggest names in diabetes tech gathered in New Orleans last weekend for the American Diabetes Association’s 86th Scientific Sessions (ADA 2026). Clinical findings supporting next-generation ...

The Flex CGM system [Image courtesy of Dexcom] Dexcom (Nasdaq:DXCM) today announced the launch of Dexcom Flex, a new continuous glucose monitor (CGM) for adults with type 2 diabetes. Flex targets ...